Apoliprotein E-epsylon4 allele and CYP2D6 polymorphisms as pharmacogenetic markers in Alzheimer's disease patients treated with acetylcholinesterase inhibitors

Apoliprotein E-epsylon4 allele and CYP2D6 polymorphisms as pharmacogenetic markers in Alzheimer's disease patients treated with acetylcholinesterase inhibitors / G. Biella, F. Martinelli Boneschi, G. Magnani, M. Franceschi, D. Galimberti, E. Scarpini, R. Ghidoni, L. Benussi, R. Squitti, A. Confaloni, F. Clerici, C. Mariai, G. Forloni, D. Albani. - In: CLINICAL NEUROPATHOLOGY. - ISSN 0722-5091. - 30:3(2011), pp. 124-124. ((Intervento presentato al convegno Joint Meeting: 47. Congress of the Italian Association of Neuropathology (AINP), 37. Congress of Italian Association for Research on Brain Aging (AIRIC) tenutosi a Genova nel 2011.